Cite
MLA Citation
J.E. Huffstutter et al.. “THU0172 Symptomatic Subcutaneous Anti-Tumor Necrosis Factor-Treated Rheumatoid Arthritis Patients Respond to Golimumab following an Active Switch.” Annals of the rheumatic diseases, vol. 73, 2014, p. 240. http://access.bl.uk/ark:/81055/vdc_100135158500.0x00005a